2-178607592-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM5PP2
The NM_001267550.2(TTN):āc.53096G>Cā(p.Arg17699Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000186 in 1,613,000 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R17699H) has been classified as Likely benign.
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.53096G>C | p.Arg17699Pro | missense_variant | 277/363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.53096G>C | p.Arg17699Pro | missense_variant | 277/363 | 5 | NM_001267550.2 | ENSP00000467141 | P1 | |
TTN-AS1 | ENST00000659121.1 | n.502+9911C>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151920Hom.: 0 Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461080Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 726846
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151920Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74182
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 22, 2013 | The Arg15131Pro variant in TTN variant has not been reported in the literature, but has been identified by our laboratory in one child with HCM. This variant ha s also not been identified in large and broad European American and African Amer ican populations by the NHLBI Exome Sequencing Project (http://evs.gs.washington .edu/EVS), though it may be common in other populations. Computational analyses (biochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) suggest that the Arg15131Pro variant may impact the protein, though this information is not predictive enough to determine pathogenicity. Another variant at this position ( Arg15131His) has been identified in a small percentage of European American chro mosomes by the NHLBI Exome Sequencing Project, raising the possibility that chan ges at this position would be tolerated. In summary, additional information is n eeded to fully assess the clinical significance of the Arg15131Pro variant. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 24, 2018 | The p.R8634P variant (also known as c.25901G>C), located in coding exon 104 of the TTN gene, results from a G to C substitution at nucleotide position 25901. The arginine at codon 8634 is replaced by proline, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at